This article is more than 5 years old. Information may no longer be current.

Non-invasive stereotactic radiation comparable to surgery for NSCLC

Issue: November 25, 2010

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

52nd ASTRO Annual Meeting

SAN DIEGO — Stereotactic radiation was safe and effective for the treatment of patients with operable early-stage non-small cell lung cancer and was a noninvasive alternative to surgery with less adverse effects, according to the findings of a phase 2 study.

“We can now confirm with more confidence that stereotactic body radiation therapy is an effective treatment alternative for aged patients with early NSCLC, Yasushi Nagata, MD, professor and radiation oncologist at Hiroshima University in Hiroshima, Japan, said in a press release. “In the future, there is a possibility that radiation will be a substitute for surgery in selected patients with stage I NSCLC. I encourage patients with early lung cancer to talk to their doctors to understand all their treatment options.”

For more information:

• Nagata Y. Abstract #59. Presented at: 52nd ASTRO Annual Meeting; Oct. 31-Nov. 4, 2010; San Diego.

Follow HemOncToday.com on Twitter.